| Call Number (LC) | Title | Results |
|---|---|---|
| RS201.V43 S65 2007 | Solvent systems and their selection in pharmaceutics and biopharmaceutics / | 1 |
| RS210 .D78 2017 | Drug delivery : fundamentals & applications / | 1 |
| RS250 .R245 | Drug topics red book. | 1 |
| RS 250 .R245 1941-1944 | Drug topics red book. | 1 |
| Your match would be here. | ||
| RS 250 .R245 1945-1992 | Drug topics red book. | 1 |
| RS 250 .R245 1993-1994 | Red book. | 1 |
| RS355 .A48 2013 | American drug index 2013 / | 1 |
| RS355 .C38 1828 | Catalogue of the materia medica, and of the pharmaceutical preparations : with the uniform prices of the Mass. College of Pharmacy. | 1 |
| RS356 .A537 |
Blue book / Blue book, American druggist. |
2 |
| RS 356 .A537 1928-1987 | American druggist blue book. | 1 |
| RS 356 .A537 1987-1992 | Blue book, American druggist. | 1 |
| RS 356 .A537 1994- | Blue book / | 1 |
| RS356 .M56 | Merck's report ready-reference : designed for use at the prescription counter and pharmaceutical laboratory ... | 1 |
| RS 356 .M56 1900 | Merck's report ready-reference : designed for use at the prescription counter and pharmaceutical laboratory ... | 1 |
| RS356 .P53 | Pharmaceutical activities index-directory : Pharm-AID. | 1 |
| RS380 |
Biotechnology and biopharmaceuticals : transforming proteins and genes into drugs / PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / Biopharmaceutical production technology / Biosimilars and biologics : implementation and monitoring in a healthcare setting / Controlled release in oral drug delivery Formulating Poorly Water Soluble Drugs Biosimilars Regulatory, Clinical, and Biopharmaceutical Development / Advances in Pharma Business Management and Research Volume 1 / CRO - Contract Research Organization. Gene jockeys : life science and the making of the first biotech drugs / Continuous biomanufacturing : innovative technologies and methods / Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account : RIFT-LINES WITHIN EUROPEAN REGULATORY FRAMEWORK FOR BIOSIMILARS WHEN TAKING HETEROGENEITY AND VARIATION DURING LIFECYCLE OF THE REFERENCE BIOLOGIC AND THE BIOSIMILAR INTO ACCOUNT. |
12 |
| RS380 .B53 2010 | Biodrug delivery systems : fundamentals, applications and clinical development / | 1 |
| RS380 .C45 2014 | Biosimilars : Design and Analysis of Follow-on Biologics. | 1 |
| RS 380 .D48 1997 | Development of biopharmaceutical parenteral dosage forms / | 1 |
| RS380 .D48 1997 | Development of biopharmaceutical parenteral dosage forms / | 1 |
